世界の腫瘍学ベース分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Oncology Based Molecular Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4254 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、腫瘍学ベース分子診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、試薬）、用途別市場規模（乳がん、前立腺がん、結腸直腸がん、子宮頸がん、肝臓がん、肺がん、血液がん、腎臓がん）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・腫瘍学ベース分子診断の市場動向 ・企業の競争状況、市場シェア ・腫瘍学ベース分子診断の種類別市場規模（機器、試薬） ・腫瘍学ベース分子診断の用途別市場規模（乳がん、前立腺がん、結腸直腸がん、子宮頸がん、肝臓がん、肺がん、血液がん、腎臓がん） ・腫瘍学ベース分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍学ベース分子診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍学ベース分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍学ベース分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍学ベース分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Bayer Healthcare、Beckton Dickinson、Cepheid、Dako、Hologic、Qiagen、Roche、Siemens Healthineers、Sysmex） ・結論

Market Analysis and Insights: Global Oncology Based Molecular Diagnostic Market
The global Oncology Based Molecular Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Based Molecular Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Based Molecular Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Based Molecular Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Based Molecular Diagnostic market.

Global Oncology Based Molecular Diagnostic Scope and Market Size
Oncology Based Molecular Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Based Molecular Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Instruments
Reagents

Segment by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Liver Cancer
Lung Cancer
Blood Cancer
Kidney Cancer

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Bayer Healthcare
Beckton Dickinson
Cepheid
Dako
Hologic
Qiagen
Roche
Siemens Healthineers

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Based Molecular Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instruments
1.2.3 Reagents
1.3 Market by Application
1.3.1 Global Oncology Based Molecular Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Cervical Cancer
1.3.6 Liver Cancer
1.3.7 Lung Cancer
1.3.8 Blood Cancer
1.3.9 Kidney Cancer
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oncology Based Molecular Diagnostic Market Perspective (2016-2027)
2.2 Oncology Based Molecular Diagnostic Growth Trends by Regions
2.2.1 Oncology Based Molecular Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncology Based Molecular Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Based Molecular Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Oncology Based Molecular Diagnostic Industry Dynamic
2.3.1 Oncology Based Molecular Diagnostic Market Trends
2.3.2 Oncology Based Molecular Diagnostic Market Drivers
2.3.3 Oncology Based Molecular Diagnostic Market Challenges
2.3.4 Oncology Based Molecular Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oncology Based Molecular Diagnostic Players by Revenue
3.1.1 Global Top Oncology Based Molecular Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Oncology Based Molecular Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Oncology Based Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Based Molecular Diagnostic Revenue
3.4 Global Oncology Based Molecular Diagnostic Market Concentration Ratio
3.4.1 Global Oncology Based Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Based Molecular Diagnostic Revenue in 2020
3.5 Oncology Based Molecular Diagnostic Key Players Head office and Area Served
3.6 Key Players Oncology Based Molecular Diagnostic Product Solution and Service
3.7 Date of Enter into Oncology Based Molecular Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Based Molecular Diagnostic Breakdown Data by Type
4.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Type (2022-2027)

5 Oncology Based Molecular Diagnostic Breakdown Data by Application
5.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oncology Based Molecular Diagnostic Market Size (2016-2027)
6.2 North America Oncology Based Molecular Diagnostic Market Size by Type
6.2.1 North America Oncology Based Molecular Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Oncology Based Molecular Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Oncology Based Molecular Diagnostic Market Size by Type (2016-2027)
6.3 North America Oncology Based Molecular Diagnostic Market Size by Application
6.3.1 North America Oncology Based Molecular Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Oncology Based Molecular Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Oncology Based Molecular Diagnostic Market Size by Application (2016-2027)
6.4 North America Oncology Based Molecular Diagnostic Market Size by Country
6.4.1 North America Oncology Based Molecular Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Oncology Based Molecular Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Oncology Based Molecular Diagnostic Market Size (2016-2027)
7.2 Europe Oncology Based Molecular Diagnostic Market Size by Type
7.2.1 Europe Oncology Based Molecular Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Oncology Based Molecular Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Oncology Based Molecular Diagnostic Market Size by Type (2016-2027)
7.3 Europe Oncology Based Molecular Diagnostic Market Size by Application
7.3.1 Europe Oncology Based Molecular Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Oncology Based Molecular Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Oncology Based Molecular Diagnostic Market Size by Application (2016-2027)
7.4 Europe Oncology Based Molecular Diagnostic Market Size by Country
7.4.1 Europe Oncology Based Molecular Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Oncology Based Molecular Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oncology Based Molecular Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Type
8.2.1 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Application
8.3.1 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region
8.4.1 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oncology Based Molecular Diagnostic Market Size (2016-2027)
9.2 Latin America Oncology Based Molecular Diagnostic Market Size by Type
9.2.1 Latin America Oncology Based Molecular Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Oncology Based Molecular Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Oncology Based Molecular Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Oncology Based Molecular Diagnostic Market Size by Application
9.3.1 Latin America Oncology Based Molecular Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Oncology Based Molecular Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Oncology Based Molecular Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Oncology Based Molecular Diagnostic Market Size by Country
9.4.1 Latin America Oncology Based Molecular Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Oncology Based Molecular Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oncology Based Molecular Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Type
10.2.1 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Application
10.3.1 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country
10.4.1 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Oncology Based Molecular Diagnostic Introduction
11.1.4 Abbott Revenue in Oncology Based Molecular Diagnostic Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Details
11.2.2 Bayer Healthcare Business Overview
11.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Introduction
11.2.4 Bayer Healthcare Revenue in Oncology Based Molecular Diagnostic Business (2016-2021)
11.2.5 Bayer Healthcare Recent Development
11.3 Beckton Dickinson
11.3.1 Beckton Dickinson Company Details
11.3.2 Beckton Dickinson Business Overview
11.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Introduction
11.3.4 Beckton Dickinson Revenue in Oncology Based Molecular Diagnostic Business (2016-2021)
11.3.5 Beckton Dickinson Recent Development
11.4 Cepheid
11.4.1 Cepheid Company Details
11.4.2 Cepheid Business Overview
11.4.3 Cepheid Oncology Based Molecular Diagnostic Introduction
11.4.4 Cepheid Revenue in Oncology Based Molecular Diagnostic Business (2016-2021)
11.4.5 Cepheid Recent Development
11.5 Dako
11.5.1 Dako Company Details
11.5.2 Dako Business Overview
11.5.3 Dako Oncology Based Molecular Diagnostic Introduction
11.5.4 Dako Revenue in Oncology Based Molecular Diagnostic Business (2016-2021)
11.5.5 Dako Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic Oncology Based Molecular Diagnostic Introduction
11.6.4 Hologic Revenue in Oncology Based Molecular Diagnostic Business (2016-2021)
11.6.5 Hologic Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Oncology Based Molecular Diagnostic Introduction
11.7.4 Qiagen Revenue in Oncology Based Molecular Diagnostic Business (2016-2021)
11.7.5 Qiagen Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Oncology Based Molecular Diagnostic Introduction
11.8.4 Roche Revenue in Oncology Based Molecular Diagnostic Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Details
11.9.2 Siemens Healthineers Business Overview
11.9.3 Siemens Healthineers Oncology Based Molecular Diagnostic Introduction
11.9.4 Siemens Healthineers Revenue in Oncology Based Molecular Diagnostic Business (2016-2021)
11.9.5 Siemens Healthineers Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Details
11.10.2 Sysmex Business Overview
11.10.3 Sysmex Oncology Based Molecular Diagnostic Introduction
11.10.4 Sysmex Revenue in Oncology Based Molecular Diagnostic Business (2016-2021)
11.10.5 Sysmex Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oncology Based Molecular Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instruments
Table 3. Key Players of Reagents
Table 4. Global Oncology Based Molecular Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Oncology Based Molecular Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oncology Based Molecular Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Oncology Based Molecular Diagnostic Market Share by Regions (2016-2021)
Table 8. Global Oncology Based Molecular Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Oncology Based Molecular Diagnostic Market Share by Regions (2022-2027)
Table 10. Oncology Based Molecular Diagnostic Market Trends
Table 11. Oncology Based Molecular Diagnostic Market Drivers
Table 12. Oncology Based Molecular Diagnostic Market Challenges
Table 13. Oncology Based Molecular Diagnostic Market Restraints
Table 14. Global Oncology Based Molecular Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Oncology Based Molecular Diagnostic Market Share by Players (2016-2021)
Table 16. Global Top Oncology Based Molecular Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Based Molecular Diagnostic as of 2020)
Table 17. Ranking of Global Top Oncology Based Molecular Diagnostic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Oncology Based Molecular Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oncology Based Molecular Diagnostic Product Solution and Service
Table 21. Date of Enter into Oncology Based Molecular Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oncology Based Molecular Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Oncology Based Molecular Diagnostic Revenue Market Share by Type (2016-2021)
Table 25. Global Oncology Based Molecular Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Oncology Based Molecular Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Oncology Based Molecular Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Oncology Based Molecular Diagnostic Revenue Market Share by Application (2016-2021)
Table 29. Global Oncology Based Molecular Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Oncology Based Molecular Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Oncology Based Molecular Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Oncology Based Molecular Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Oncology Based Molecular Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Oncology Based Molecular Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Oncology Based Molecular Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Oncology Based Molecular Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Oncology Based Molecular Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Oncology Based Molecular Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Oncology Based Molecular Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Oncology Based Molecular Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Oncology Based Molecular Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Oncology Based Molecular Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Oncology Based Molecular Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Oncology Based Molecular Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Oncology Based Molecular Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Oncology Based Molecular Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Oncology Based Molecular Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Oncology Based Molecular Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Oncology Based Molecular Diagnostic Product
Table 64. Abbott Revenue in Oncology Based Molecular Diagnostic Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Bayer Healthcare Company Details
Table 67. Bayer Healthcare Business Overview
Table 68. Bayer Healthcare Oncology Based Molecular Diagnostic Product
Table 69. Bayer Healthcare Revenue in Oncology Based Molecular Diagnostic Business (2016-2021) & (US$ Million)
Table 70. Bayer Healthcare Recent Development
Table 71. Beckton Dickinson Company Details
Table 72. Beckton Dickinson Business Overview
Table 73. Beckton Dickinson Oncology Based Molecular Diagnostic Product
Table 74. Beckton Dickinson Revenue in Oncology Based Molecular Diagnostic Business (2016-2021) & (US$ Million)
Table 75. Beckton Dickinson Recent Development
Table 76. Cepheid Company Details
Table 77. Cepheid Business Overview
Table 78. Cepheid Oncology Based Molecular Diagnostic Product
Table 79. Cepheid Revenue in Oncology Based Molecular Diagnostic Business (2016-2021) & (US$ Million)
Table 80. Cepheid Recent Development
Table 81. Dako Company Details
Table 82. Dako Business Overview
Table 83. Dako Oncology Based Molecular Diagnostic Product
Table 84. Dako Revenue in Oncology Based Molecular Diagnostic Business (2016-2021) & (US$ Million)
Table 85. Dako Recent Development
Table 86. Hologic Company Details
Table 87. Hologic Business Overview
Table 88. Hologic Oncology Based Molecular Diagnostic Product
Table 89. Hologic Revenue in Oncology Based Molecular Diagnostic Business (2016-2021) & (US$ Million)
Table 90. Hologic Recent Development
Table 91. Qiagen Company Details
Table 92. Qiagen Business Overview
Table 93. Qiagen Oncology Based Molecular Diagnostic Product
Table 94. Qiagen Revenue in Oncology Based Molecular Diagnostic Business (2016-2021) & (US$ Million)
Table 95. Qiagen Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Revenue in Oncology Based Molecular Diagnostic Business (2016-2021) & (US$ Million)
Table 99. Roche Recent Development
Table 100. Siemens Healthineers Company Details
Table 101. Siemens Healthineers Business Overview
Table 102. Siemens Healthineers Oncology Based Molecular Diagnostic Product
Table 103. Siemens Healthineers Revenue in Oncology Based Molecular Diagnostic Business (2016-2021) & (US$ Million)
Table 104. Siemens Healthineers Recent Development
Table 105. Sysmex Company Details
Table 106. Sysmex Business Overview
Table 107. Sysmex Oncology Based Molecular Diagnostic Product
Table 108. Sysmex Revenue in Oncology Based Molecular Diagnostic Business (2016-2021) & (US$ Million)
Table 109. Sysmex Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Based Molecular Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Instruments Features
Figure 3. Reagents Features
Figure 4. Global Oncology Based Molecular Diagnostic Market Share by Application: 2020 VS 2027
Figure 5. Breast Cancer Case Studies
Figure 6. Prostate Cancer Case Studies
Figure 7. Colorectal Cancer Case Studies
Figure 8. Cervical Cancer Case Studies
Figure 9. Liver Cancer Case Studies
Figure 10. Lung Cancer Case Studies
Figure 11. Blood Cancer Case Studies
Figure 12. Kidney Cancer Case Studies
Figure 13. Oncology Based Molecular Diagnostic Report Years Considered
Figure 14. Global Oncology Based Molecular Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Oncology Based Molecular Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Oncology Based Molecular Diagnostic Market Share by Regions: 2020 VS 2027
Figure 17. Global Oncology Based Molecular Diagnostic Market Share by Regions (2022-2027)
Figure 18. Global Oncology Based Molecular Diagnostic Market Share by Players in 2020
Figure 19. Global Top Oncology Based Molecular Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Based Molecular Diagnostic as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Oncology Based Molecular Diagnostic Revenue in 2020
Figure 21. Global Oncology Based Molecular Diagnostic Revenue Market Share by Type (2016-2021)
Figure 22. Global Oncology Based Molecular Diagnostic Revenue Market Share by Type (2022-2027)
Figure 23. North America Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Oncology Based Molecular Diagnostic Market Share by Type (2016-2027)
Figure 25. North America Oncology Based Molecular Diagnostic Market Share by Application (2016-2027)
Figure 26. North America Oncology Based Molecular Diagnostic Market Share by Country (2016-2027)
Figure 27. United States Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Oncology Based Molecular Diagnostic Market Share by Type (2016-2027)
Figure 31. Europe Oncology Based Molecular Diagnostic Market Share by Application (2016-2027)
Figure 32. Europe Oncology Based Molecular Diagnostic Market Share by Country (2016-2027)
Figure 33. Germany Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Oncology Based Molecular Diagnostic Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Oncology Based Molecular Diagnostic Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Oncology Based Molecular Diagnostic Market Share by Region (2016-2027)
Figure 43. China Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Oncology Based Molecular Diagnostic Market Share by Type (2016-2027)
Figure 51. Latin America Oncology Based Molecular Diagnostic Market Share by Application (2016-2027)
Figure 52. Latin America Oncology Based Molecular Diagnostic Market Share by Country (2016-2027)
Figure 53. Mexico Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Oncology Based Molecular Diagnostic Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Oncology Based Molecular Diagnostic Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Oncology Based Molecular Diagnostic Market Share by Country (2016-2027)
Figure 59. Turkey Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Oncology Based Molecular Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abbott Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2016-2021)
Figure 63. Bayer Healthcare Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2016-2021)
Figure 64. Beckton Dickinson Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2016-2021)
Figure 65. Cepheid Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2016-2021)
Figure 66. Dako Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2016-2021)
Figure 67. Hologic Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2016-2021)
Figure 68. Qiagen Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2016-2021)
Figure 70. Siemens Healthineers Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2016-2021)
Figure 71. Sysmex Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---